Primo Nutraceuticals Inc.
BUGVF
OTC PK
| 04/30/2020 | 01/31/2020 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 414.17% | -90.35% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 414.17% | -90.35% | |||
| Operating Income | -414.17% | 90.35% | |||
| Income Before Tax | -195.35% | 83.28% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -195.35% | 83.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -195.35% | 83.28% | |||
| EBIT | -414.17% | 90.35% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -188.57% | 87.99% | |||
| Normalized Basic EPS | -384.62% | 92.88% | |||
| EPS Diluted | -188.57% | 87.99% | |||
| Normalized Diluted EPS | -384.62% | 92.88% | |||
| Average Basic Shares Outstanding | 2.28% | 39.60% | |||
| Average Diluted Shares Outstanding | 2.28% | 39.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
